Literature DB >> 8996653

Collagen and glycosaminoglycans of Wharton's jelly.

K Sobolewski1, E Bańkowski, L Chyczewski, S Jaworski.   

Abstract

In this study, we report quantity, solubility and molecular polymorphism of collagen, proportional relationships between various types of collagen, ultrastructure of collagen fibres, the amounts of various glycosaminoglycans (GAGs) and proportional relationships between them in Wharton's jelly of normal umbilical cords. We compare the extracellular matrix components in Wharton's jelly with those in the umbilical cord artery. Collagen of the Wharton's jelly demonstrates some specific features. It is very insoluble in neutral salt and in a slightly acidic solution and appears to be resistant to the action of depolymerizing agent (EDTA-Na2). Only 50% of total collagen may be solubilized by pepsin digestion and fractionated by differential salt precipitation. Four collagen fractions were obtained. Three of them were identified by polyacrylamide gel electrophoresis as type I, type III, and type V collagen and proportional relationship between them was calculated. Hyaluronic acid is the most abundant component of GAGs contained in Wharton's jelly. The amounts of sulphated GAGs-keratan sulphate, heparan sulphate, chondroitin-4-sulphate, chondroitin-6-sulphate, dermatan sulphate and heparin-are distinctly lower. Each of them constitutes only a few percent of total GAGs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996653     DOI: 10.1159/000244392

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  24 in total

1.  Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Authors:  Annamaria Mauro; Maria Buscemi; Aldo Gerbino
Journal:  J Mol Histol       Date:  2010-10-10       Impact factor: 2.611

2.  Stem cells for reprogramming: could hUMSCs be a better choice?

Authors:  Paulina Duya; Yuhong Bian; Xiaoqian Chu; Yanjun Zhang
Journal:  Cytotechnology       Date:  2012-09-12       Impact factor: 2.058

3.  Development of a mechanically tuneable 3D scaffold for vascular reconstruction.

Authors:  Maritza Rodriguez; Cassandra Juran; Mark McClendon; Cyril Eyadiel; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

4.  ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation.

Authors:  Sumeda Nandadasa; Courtney M Nelson; Suneel S Apte
Journal:  Cell Rep       Date:  2015-05-28       Impact factor: 9.423

5.  The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration.

Authors:  Roger W Chan; Maritza L Rodriguez; Peter S McFetridge
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

6.  TGF-beta binding in human Wharton's jelly.

Authors:  Andrzej Małkowski; Krzysztof Sobolewski; Stefan Jaworski; Edward Bańkowski
Journal:  Mol Cell Biochem       Date:  2008-01-24       Impact factor: 3.396

7.  Lipid compounds of human Wharton's jelly and their alterations in preeclampsia.

Authors:  Lech Romanowicz; Edward Bańkowski
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

8.  Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1.

Authors:  Salina M Torres; Dale M Walker; Consuelo L McCash; Meghan M Carter; Jessica Ming; Edmund M Cordova; Rachel M Pons; Dennis L Cook; Steven K Seilkop; William C Copeland; Vernon E Walker
Journal:  Environ Mol Mutagen       Date:  2009-01       Impact factor: 3.216

Review 9.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

10.  Area of Wharton's jelly as an estimate of the thickness of the umbilical cord and its relationship with estimated fetal weight.

Authors:  Cristiane Barbieri; Jose G Cecatti; Fernanda G Surita; Maria L Costa; Emilio F Marussi; Jose V Costa
Journal:  Reprod Health       Date:  2011-11-04       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.